Evidence map›Paper›PMID 41138212›Full record

ArticleAmerican journal of physiology. Renal physiology2025

Uremic serum exposure leads to differential phenotypic switch in porcine arterial and venous smooth muscle cells.

Huanjuan Su, Unimunkh Uriyanghai, Christine Wai, Eyla C Arteaga, Haibao Wan, Klaus-Peter Adam, Vinay A Sudarsanam, Samuel O'Brien Haddad, Anthony Yang, Lianxia Li and 4 more

Abstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Huanjuan SuUNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
Unimunkh UriyanghaiUNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
Christine WaiUNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
Eyla C ArteagaUNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
Haibao WanPrecion, Inc., Morrisville, North Carolina, United States.
Klaus-Peter AdamPrecion, Inc., Morrisville, North Carolina, United States.
Vinay A SudarsanamUNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
Samuel O'Brien HaddadUNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.ORCID 0009-0008-2875-4708
Anthony YangUNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.ORCID 0009-0002-3692-7820
Lianxia LiUNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.ORCID 0009-0007-0469-7588
Edward M BahnsonUNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.ORCID 0000-0001-8578-0517
John S PoultonUNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
Prabir Roy-ChaudhuryUNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
Gang XiUNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.ORCID 0000-0002-7020-1831

Funding

Modulation of VSMC phenotype through the Insulin Receptor Substrate-1/Kruppel-like factor-4 signal transduction pathway: a Novel Target for AVF DysfunctionR01DK132328 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PRABIR ROY-CHAUDHURY, Gang Xi · 2022 to 2026
$2.7M
HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) R01 DK132328-03NIDDK NIH HHS R01 DK132328
6 · The paper itself

Abstract

Many patients with end-stage kidney disease (ESKD) frequently suffer from both aggressive vascular access stenosis in the venous segment of arteriovenous fistula or arteriovenous graft, and widespread cardiovascular disease (CVD) or peripheral arterial disease (PAD). Despite the magnitude of these clinical problems, the pathogenic role of the uremic state in both of these conditions remains unclear. To investigate the underlying mechanisms, we used porcine-derived arterial smooth muscle cells (ApSMCs) and venous smooth muscle cells (VpSMCs) to examine several key aspects of cell behavior in response to uremic serum. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay demonstrated that 30% of uremic serum was able to stimulate the proliferation of both subtypes of cells equally. Cell migration, measured by the scratch assay, showed that uremic serum increased migration of both cells, but was more robust in VpSMCs. Importantly, uremic serum induced phenotypic switching (e.g., dedifferentiation) in both subtypes of cells, as indicated by increased proliferating cell nuclear antigen expression and reduced calponin expression. Intriguingly, we found that several key aspects of this uremia-induced phenotypic switch were stronger in ApSMCs as compared with VpSMCs, including the production of extracellular matrix (ECM) proteins, such as fibronectin, cellular calcification [high expression of RUNX family transcription factor 2 (Runx2), alkaline phosphatase (ALP), and Krüppel-like factor 4 (KLF-4)], and a proinflammatory state [high expression of tumor necrosis factor-α (TNF-α) and interleukin 6 (IL-6)]. Our findings suggest that uremia plays an important role in both the aggressive arteriovenous stenosis and CVD/PAD that affect many patients undergoing hemodialysis. This information could contribute to the development of novel uremia-specific therapies for both vascular access dysfunction and CVD/PAD in patients with ESKD.

Indexed as

Muscle, Smooth, VascularMyocytes, Smooth MuscleUremiaVeinsAnimalsCell MovementCell ProliferationCells, CulturedKruppel-Like Factor 4PhenotypeSwineKLF4 protein, humanKruppel-Like Factor 4cardiovascular diseaseperipheral arterial diseaseuremiavascular accessvascular smooth muscle cells

Identifiers

PMID41138212
PMCPMC13005601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.